Genetics-testing company 23andMe has lost almost a third of its value over the past week as former investors and board members, including Sequoia Capital, sold shares in the once much-hyped Silicon Valley group.
过去一周，基因检测公司23andMe的价值下跌了近三分之一，包括红杉资本在内的前投资者和董事会成员出售了这家曾经被热捧的硅谷集团的股票。
您已阅读6%（279字），剩余94%（4585字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。